Neurotrophic stimulation therapy for the management of generalized anxiety disorder and depression a review of the clinical effectiveness
Centers offering neurotrophic stimulation as an approach to managing mental health disorders are available in Canada. The objective of this report is to review the literature for evidence of clinical effectiveness for the use of any component of neurotrophic stimulation alone or in combination with...
| Corporate Author: | |
|---|---|
| Format: | eBook |
| Language: | English |
| Published: |
Ottawa (ON)
Canadian Agency for Drugs and Technologies in Health
20 August 2015, 2015
|
| Series: | Rapid response report : summary with critical appraisal
|
| Subjects: | |
| Online Access: | |
| Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
| Summary: | Centers offering neurotrophic stimulation as an approach to managing mental health disorders are available in Canada. The objective of this report is to review the literature for evidence of clinical effectiveness for the use of any component of neurotrophic stimulation alone or in combination with another component in patients with depression or generalized anxiety disorder (GAD). A previous report addressed the clinical effectiveness of neurotrophic stimulation in post-traumatic stress disorder (PTSD) and substance abuse disorders |
|---|---|
| Physical Description: | 1 PDF file (29 pages) illustration |